Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: An immunohistochemical study

World Journal of Surgery

Volumn 31, Issue 9, 2007, Pages 1737-1742

  Mishra, Anjali ^a   Pal, Lily ^a   Mishra, Saroj Kanta ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IODINE DEFICIENCY; LYMPH NODE METASTASIS; MALE; METASTASIS; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; SEX DIFFERENCE; THYROID CANCER; THYROID CARCINOMA; TUMOR VOLUME; WHOLE BODY RADIATION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; GOITER, ENDEMIC; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SYMPORTERS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548052656     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9156-6     Document Type: Article

References (26)

1. Franceschi S. (1998) Iodine intake and thyroid carcinoma-a potential risk factor. Exp Clin Endocrinol Diabetes 106:S38-44
2. Lind P, Langsteger W, Molnar M, et al. (1998) Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179-1183
3. Kalk WJ, Sitas F, Patterson AC. (1997) Thyroid cancer in South Africa- an indicator of iodine deficiency. S Afr Med J 87:735-738
4. Bakiri F, Djemli FK, Mokrane LA, et al. (1998) The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 82:1146-1153
5. Fang WT, Qao BS, Wang JB. (1994) Iodine deficiency induces thyroid cancers in rats and mice Zhounghua Zhong Liu Za Zhi 16:341-344
6. Dai G, Levy O, Carrasco N. (1996) Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460
7. Smanik PA, Liu Q, Furminger TL, et al. (1996) Cloning of the human sodium iodide symporter. Biophys Res Commun 226:339-345
8. Castro MR, Berget ER, Beito TG, et al. (1999) Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab 84:2957-2962
9. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234
10. Arturi F, Russo D, Shlumberger M, et al. (1998) Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83:2493-2496
11. - symporter in human thyroid tissue and salivary gland tissue. Endocrinology 139:4416-4419
12. Calliou B, Troalen F, Baudin E, et al. (1998) Na+/I- symporter distribution in human thyroid tissue: an immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106
13. Shimura H, Haraguchi K, Myazaki A, et al. (1997) Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Endocrinology 138:4493-4496
14. Venkataraman GM, Yatin M, Marcinek R, et al. (1999) Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I- symporter gene methylation status. J Clin Endocrinol Metab 84:2449-2457
15. Spitzweg C, Heufelder AE, Morris JC. (2000) Thyroid iodine transport. Thyroid 10:321-330
16. Filetti S, Bidart JM, Arturi F, et al. (1999) Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457
17. Park H-J, Kim JY, Gong G, et al. (2000) Expression of sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid 10:211-217
18. Wapnir IL, van de Rijn M, Nowels K, et al. (2003) Immunohistochemical profile of the sodium/ iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88:1880-1888
19. Saito T, Endo T, Kawaguchi A, et al. (1998) Increases expression of the sodium/ iodide symporter in papillary thyroid carcinomas. J Clin Invest 101:1296-1300
20. Dohan O, Baloch Z, Banrevi Z, et al. (2001) Predominant intracellular overexpression of Na+/I- symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697-2700
21. Patel S, Jhiang S, Dogra S, et al. (2002) Differentiated thyroid carcinoma that express sodium-iodide symporter has a lower risk of recurrence for children and adolescents. Pediatr Res 52:737-744
22. Ward LS, Santarosa PL, Granja F, et al. (2003) Low expression of sodium iodide symporter identifies aggressive thyroid tumors. Cancer Lett 200:85-91
23. Lind JD, Chan EC, Chao TC, et al. (2000) Expression of sodium iodide symporter in metastatic and follicular human thyroid tissue. Ann Oncol 11:625-629
24. Castro M, Bergert ER, Goellner JR, et al. (2001) Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer; correlation with radioiodine uptake. J Clin Endocrinol Metab 86:5627-5632
25. McDougall R. (1995) Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples. Clin Nucl Med 20:869-875
26. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, et al. (2004) Evidence for transcriptional and post-transcriptional alterations of the sodium/iodide symporter in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 165:25-34